Do-Hyun Nam
Net worth: 506 M $ as of 2026-05-30
Net worth: 506 M $ as of 2026-05-30
Dr. Do-Hyun Nam is a Chairman & Chief Technology Officer at Aimed Bio, Inc. and a Chief Executive Officer at Clipsoft Co. Ltd. Dr. Nam was previously employed as a Director-Refractory Cancer Research Institute by Samsung Medical Center and a Professor by Sungkyunkwan University.
He received his graduate degree from Seoul National University College of Medicine and a doctorate degree from Seoul National University College of Medicine.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AIMED BIO INC. 34.27% | 2025-12-09 | 22,164,757 ( 34.27% ) | 506 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| AIMED BIO INC. | Founder | 2018-08-26 |
Clipsoft Co. Ltd.
Clipsoft Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Provides digital document production services | Chief Executive Officer | - |
| Companies | Position | End |
|---|---|---|
Sungkyunkwan University
Sungkyunkwan University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Samsung Medical Center
Samsung Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 5 |
|---|---|
Sungkyunkwan University
Sungkyunkwan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Samsung Medical Center
Samsung Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Health Services |
Clipsoft Co. Ltd.
Clipsoft Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Provides digital document production services | Commercial Services |
Seoul National University College of Medicine
Seoul National University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aimed Bio, Inc.
Aimed Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions